Geisbüsch, Christina
Herweh, Christian
Gumbinger, Christoph
Ringleb, Peter A.
Möhlenbruch, Markus A.
Nagel, Simon https://orcid.org/0000-0003-2471-6647
Article History
Received: 16 February 2021
Accepted: 4 May 2021
First Online: 17 May 2021
Declarations
:
: This study was approved by our local ethics committee (S-821/2019), medical faculty of University of Heidelberg. Patient informed consent waived due to the retrospective nature of the study.
: N.A.
: Christina Geisbüsch—none.Christian Herweh—UNRELATED: Consultancy: Brainomix, Oxford, UK,Christoph Gumbinger—UNRELATED: Speaker of the commission teleneurology service of the German Stroke Society.Peter A. Ringleb—UNRELATED: Consultancy: Boehringer, Lecture fees from Bayer, Boehringer Ingelheim, BMS, Daichii Sankyo, Pfizer.Markus A. Möhlenbruch—UNRELATED: Board Membership: Codman; Consultancy: Medtronic, MicroVention, Stryker; Payment for Lectures Including Service on Speakers Bureaus: Medtronic, MicroVention, Stryker. *Money paid to the institution.Simon Nagel—UNRELATED: Consultancy: Brainomix, Boehringer Ingelheim; Payment for Lectures Including Service on Speakers Bureaus: Pfizer, Medtronic, Bayer AG.